mirror of
https://github.com/msberends/AMR.git
synced 2026-11-16 05:00:50 +01:00
(v3.1.0.9011) Use top_n_microorganisms() in the WISCA examples of the index, manual and vignette, and reword the WISCA prior weight warning to also cover small groups (#337)
This commit is contained in:
1 parent
fdfdadae14
commit
944078c4bc
7 files changed
+33
-30
No files matched your search
+9
-8
@@ -158,7 +158,7 @@
|
||||
#'
|
||||
#' **Pathogens included in the model:** For each regimen (and group), only pathogens that occur in the data and have at least one test result for the regimen are included. Pathogens without any test result for a regimen do not contribute to its coverage, nor to its `n_total` in `long_numeric`. Use [retrieve_wisca_parameters()] to get the parameters that were used.
|
||||
#'
|
||||
#' **Rare pathogens:** Since every pathogen receives a prior weight of 1 in the Dirichlet distribution, pathogens found only once or a few times are given relatively much weight, which pulls the incidence towards a uniform distribution. Their very uncertain susceptibility can then strongly lower the estimated coverage, without reflecting the clinical expectation. A warning is therefore given when this prior weight accounts for more than 5% of the pathogen incidence in any regimen (or group). Consider limiting the analysis to the most common pathogens using [top_n_microorganisms()], or grouping rare pathogens before running WISCA.
|
||||
#' **Rare pathogens and small groups:** Since every pathogen receives a prior weight of 1 in the Dirichlet distribution, the prior weighs heavily when there are few isolates relative to the number of pathogens, i.e., with pathogens found only once or a few times, or in small groups. This pulls the incidence towards a uniform distribution, and the very uncertain susceptibility of rare pathogens can then strongly lower the estimated coverage, without reflecting the clinical expectation. A warning is therefore given when this prior weight accounts for more than 5% of the pathogen incidence in any regimen (or group). Consider limiting the analysis to the most common pathogens using [top_n_microorganisms()], or using fewer and larger groups.
|
||||
#'
|
||||
#' **Interpreting the output:** Overlapping credible intervals between regimens indicate no significant difference in coverage; if a narrower-spectrum regimen overlaps with a broader one, the narrower-spectrum option may be preferred on stewardship grounds. Non-overlapping intervals indicate a clinically meaningful difference. For small sample sizes, consider pooling data from multiple sites to improve precision, provided pathogen distributions are sufficiently similar (Bielicki *et al.*, 2016).
|
||||
#'
|
||||
@@ -186,12 +186,13 @@
|
||||
#'
|
||||
#' # basic WISCA: empirical coverage per regimen, weighted by pathogen
|
||||
#' # incidence, with 95% credible intervals
|
||||
#' wisca(example_isolates,
|
||||
#' # (10 most common species, since rare species can distort coverage estimates)
|
||||
#' wisca(top_n_microorganisms(example_isolates, n = 10),
|
||||
#' antimicrobials = c("AMC", "AMC+CIP", "AMC+GEN")
|
||||
#' )
|
||||
#'
|
||||
#' # equivalent using antibiogram():
|
||||
#' antibiogram(example_isolates,
|
||||
#' antibiogram(top_n_microorganisms(example_isolates, n = 10),
|
||||
#' antimicrobials = c("AMC", "AMC+CIP", "AMC+GEN"),
|
||||
#' wisca = TRUE
|
||||
#' )
|
||||
@@ -276,7 +277,7 @@
|
||||
#'
|
||||
#' # Print the output for R Markdown / Quarto -----------------------------
|
||||
#'
|
||||
#' ureido <- wisca(example_isolates,
|
||||
#' ureido <- wisca(top_n_microorganisms(example_isolates, n = 10),
|
||||
#' antimicrobials = ureidopenicillins(),
|
||||
#' syndromic_group = "ward"
|
||||
#' )
|
||||
@@ -294,7 +295,7 @@
|
||||
#' antimicrobials = c("AMC", "CIP", "TZP", "TZP+TOB"),
|
||||
#' mo_transform = "gramstain"
|
||||
#' )
|
||||
#' ab2 <- wisca(example_isolates,
|
||||
#' ab2 <- wisca(top_n_microorganisms(example_isolates, n = 10),
|
||||
#' antimicrobials = c("AMC", "CIP", "TZP", "TZP+TOB"),
|
||||
#' syndromic_group = "ward"
|
||||
#' )
|
||||
@@ -777,9 +778,9 @@ antibiogram.default <- function(x,
|
||||
)
|
||||
if (any(prior_share > 0.05)) {
|
||||
warning_(
|
||||
"In ", sum(prior_share > 0.05), " of ", length(prior_share), " WISCA regimen(s) or group(s), the prior weight of 1 per pathogen accounts for more than 5% of the pathogen incidence (up to ", round(max(prior_share) * 100, 1), "%), since many pathogens occur only rarely. ",
|
||||
"Because WISCA gives every pathogen a prior weight of 1 (Bielicki et al., 2016), such rare pathogens can strongly lower the estimated coverage without reflecting the clinical expectation. ",
|
||||
"Consider limiting the analysis to the most common pathogens with {.help [{.fun top_n_microorganisms}](AMR::top_n_microorganisms)}, or grouping rare pathogens before running WISCA.",
|
||||
"In ", sum(prior_share > 0.05), " of ", length(prior_share), " WISCA regimen(s) or group(s), the prior weight of 1 per pathogen accounts for more than 5% of the pathogen incidence (up to ", round(max(prior_share) * 100, 1), "%), since there are few isolates relative to the number of pathogens, i.e., rare pathogens or a small group. ",
|
||||
"Because WISCA gives every pathogen a prior weight of 1 (Bielicki et al., 2016), this can strongly lower the estimated coverage without reflecting the clinical expectation. ",
|
||||
"Consider limiting the analysis to the most common pathogens with {.help [{.fun top_n_microorganisms}](AMR::top_n_microorganisms)}, or using fewer and larger groups.",
|
||||
call = FALSE
|
||||
)
|
||||
}
|
||||
|
||||
Reference in new issue
Block a user